Breakthru Medicine — Valuation, Funding & Investors

Recent changes

Jul 29, 2026Jul 29, 2026Raised $60M Series A Fierce Biotech
Jul 29, 2026Jul 29, 2026Breakthru Medicine Launches With $60M Molecular Glue Bet Pulse story

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Jul 29, 2026	Series A	$60M	—		Pulse story

Latest Pulse

Jul 29, 2026Breakthru Medicine Launches With $60M Molecular Glue BetBreakthru Medicine emerged from stealth with a $60 million Series A to build a molecular glue platform and a pipeline of small molecules and antibody-drug conjugate payloads.→

Coverage Timeline

newest first

Jul 29, 2026FUNDINGBreakthru Medicine Launches With $60M Molecular Glue Bet$60M Series A→

All Coverage

FUNDING· Jul 29, 2026

Breakthru Medicine Launches With $60M Molecular Glue Bet

FUNDING$60M Series A

Breakthru Medicine Launches With $60M Molecular Glue Bet

Breakthru Medicine emerged from stealth with a $60 million Series A to build a molecular glue platform and a pipeline of small molecules and antibody-drug conjugate payloads.

Jul 29, 2026

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics

Sources & methodologyshow

Where these figures come from

Fierce BiotechValue Add VC data1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction